Bone manifestations in patients with Gaucher disease type 1 in southwestern Colombia

Author:

Arturo-Terranova Daniela1ORCID,Moreno-Giraldo Lina Johanna1,Satizabal-Soto Jose Maria1

Affiliation:

1. Universidad del Valle

Abstract

Abstract

Introduction: Gaucher disease (GD1) is caused by the enzymatic deficiency of β-glucocerebrosidase. This leads to accumulation of sphingolipids in organs, such as the liver, spleen, and bone marrow. Bone involvement is frequent in GD1, causing pain, necrosis and even fractures or growth deficits in children, leading to painful surgeries and progressive decrease in quality of life. Methodology: A non-experimental retrospective observational study was performed using a database of 30 patients with clinical suspicion and enzymatic and/or molecular confirmation of GD1; the numbers and percentages of occurrence for each sign were determined. Results: Bone pain was the most common symptom and was reported in 23% of the sample. 13/30 (43%) patients had report of at least one radiograph requested during the study : 6 of them, with some bone alteration, being the most frequent : increases in acetabular coverage with signs of femoroacetabular impingement, decrease in height and morphology and Erlenmeyer deformity; 14/30 (48%) of the patients presented at least one result of Magnetic Resonance Imaging (MRI); in the femur MRI of 4 patients there was a decrease in the signal intensity of the bone marrow, both in T1 and T2 sequences, involving various bone areas and changes of infiltrative bone disease; finally in 7/30 (7. 5%) presented at least one bone densitometry result (DEXA): 3 presented low bone mineralization. The patients who present the p. Asn409Ser allele may present more predisposition to bone disease. Conclusion: The present study highlights the importance of early diagnosis, to access timely treatment, to prevent bone complications typical of the disease, improving prognosis, quality of life and morbi-mortality in GD1.

Publisher

Research Square Platform LLC

Reference37 articles.

1. A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF;Vernet Machado Bressan Wilke M;Int J Mol Sci,2024

2. Pastores GM, Hughes DA. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, Amemiya A, editors. Gaucher Disease. Seattle, DC, USA: GeneReviews®. University of Washington; 1993. [(accessed on 17 September 2022)]. http://www.ncbi.nlm.nih.gov/books/NBK1269/.

3. Global Incidence and Prevalence of Gaucher Disease: A Targeted Literature Review;Castillon G;J Clin Med,2022

4. Gaucher: A Systematic Review on Oral and Radiological Aspects;Minervini G;Med (Kaunas),2023

5. ADRES. Análisis De Los Recobros Correspondientes A Los Principios Activos Imiglucerasa, Miglustato, Velaglucerasa Y, Taliglucerasa Medicamentos Para La Enfermedad De Gaucher. 2017. [Internet]. [Consultado:13 de marzo 2019]. Disponible en: https://www.adres.gov.co/La-Entidad/Publicaciones/Post/5993/An%C3%A1lisis-de-los-recobros-correspondientes-a-los-principios-activos-Imiglucerasa-Miglustato-Velaglucerasa-y-Taliglucerasa-medicamentos-para-la-enfermedad-de-Gaucher.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3